Elixinol Global logo

EXL - Elixinol Global Share Price

A$0.215 -0.0  -2.3%

Last Trade - 5:11am

Consumer Cyclicals
Micro Cap
Market Cap £23.8m
Enterprise Value £16.4m
Revenue £10.1m
Position in Universe 1142nd / 1831
Unlock EXL Revenue
Relative Strength (%)
1m +16.8%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -53.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.002 37.6 27.7 14.4 17.9 +11,678%
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, ElixinolGlobal Ltd revenues decreased 55% to A$7.9M. Net lossincreased from A$9.9M to A$81.6M. Revenues reflect OtherBusiness Related Financing Revenue decrease of 73% toA$71K. Higher net loss reflects Impairment of assetsincrease from A$184K to A$29.8M (expense), Equity Earnings-Before Taxes decrease from A$465K (income) to A$599K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


EXL Revenue Unlock EXL Revenue

Net Income

EXL Net Income Unlock EXL Revenue

Normalised EPS

EXL Normalised EPS Unlock EXL Revenue

PE Ratio Range

EXL PE Ratio Range Unlock EXL Revenue

Dividend Yield Range

EXL Dividend Yield Range Unlock EXL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
EXL EPS Forecasts Unlock EXL Revenue
Profile Summary

Elixinol Global Limited is an Australia-based company. The Company owns and operates hemp and medicinal cannabis industries. The Company is focused on developing, manufacturing and distributing industrial hemp products and early stage medical cannabis business.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated September 4, 2017
Public Since January 8, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Consumer Cyclicals
Industry Specialty Retailers
Exchange Australian Stock Exchange - SEATS
Shares in Issue 192,703,954
Free Float (0.0%)
Eligible for
EXL Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for EXL
Upcoming Events for EXL
Frequently Asked Questions for Elixinol Global
What is the Elixinol Global share price?

As of 5:11am, shares in Elixinol Global are trading at A$0.215, giving the company a market capitalisation of £23.8m. This share price information is delayed by 15 minutes.

How has the Elixinol Global share price performed this year?

Shares in Elixinol Global are currently trading at A$0.215 and the price has moved by -46.34% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Elixinol Global price has moved by -47.07% over the past year.

What are the analyst and broker recommendations for Elixinol Global?

Of the analysts with advisory recommendations for Elixinol Global, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Elixinol Global is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Elixinol Global next release its financial results?

Elixinol Global is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Elixinol Global dividend yield?

Elixinol Global does not currently pay a dividend.

Does Elixinol Global pay a dividend?

Elixinol Global does not currently pay a dividend.

When does Elixinol Global next pay dividends?

Elixinol Global does not currently pay a dividend.

How do I buy Elixinol Global shares?

To buy shares in Elixinol Global you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Elixinol Global?

Shares in Elixinol Global are currently trading at A$0.215, giving the company a market capitalisation of £23.8m.

Where are Elixinol Global shares listed? Where are Elixinol Global shares listed?

Here are the trading details for Elixinol Global:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: EXL
What kind of share is Elixinol Global?

Based on an overall assessment of its quality, value and momentum, Elixinol Global is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Elixinol Global share price forecast 2021?

Shares in Elixinol Global are currently priced at A$0.215. At that level they are trading at 0.45% premium to the analyst consensus target price of 0.00.

Analysts covering Elixinol Global currently have a consensus Earnings Per Share (EPS) forecast of -0.093 for the next financial year.

How can I tell whether the Elixinol Global share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elixinol Global. Over the past six months, the relative strength of its shares against the market has been 22.12%. At the current price of A$0.215, shares in Elixinol Global are trading at 17.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Elixinol Global PE Ratio?

We were not able to find PE ratio data for Elixinol Global.

Who are the key directors of Elixinol Global?

Elixinol Global's management team is headed by:

Paul Benhaim - NED
Linda McLeod - MDR
Ron Dufficy - CFO
Gabriel Ettenson - CTO
Greg Smith - CIO
Leif Harrison - CEX
Ali Atcha - CEX
Teresa Cleary - GCN
Oliver Horn - CEO
Helen Wiseman - NEC
Who are the major shareholders of Elixinol Global?

Here are the top five shareholders of Elixinol Global based on the size of their shareholding:

Regal Funds Management Pty. Ltd. Hedge Fund
Percentage owned: 10.15% (31.9m shares)
Raw With Life Pty. Ltd. Corporation
Percentage owned: 9.41% (29.5m shares)
D & G Health L.L.C. Corporation
Percentage owned: 3.02% (9.47m shares)
Robotexpert UG Corporation
Percentage owned: 1.05% (3.30m shares)
Tiverton Food Pty. Ltd. Corporation
Percentage owned: 0.49% (1.53m shares)
Similar to EXL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.